Detalles de la búsqueda
1.
Characteristics, origin, and potential for cancer diagnostics of ultrashort plasma cell-free DNA.
Genome Res
; 32(2): 215-227, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34930798
2.
Determinants of activity and efficacy of anti-PD1/PD-L1 therapy in patients with advanced solid tumors recruited in a clinical trials unit: a longitudinal prospective biomarker-based study.
Cancer Immunol Immunother
; 72(6): 1709-1723, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-36625938
3.
A phase I/II study of epertinib plus trastuzumab with or without chemotherapy in patients with HER2-positive metastatic breast cancer.
Breast Cancer Res
; 22(1): 1, 2019 12 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-31892325
4.
Correction to: Determinants of activity and efficacy of anti-PD1/PD-L1 therapy in patients with advanced solid tumors recruited in a clinical trials unit: a longitudinal prospective biomarker-based study.
Cancer Immunol Immunother
; 72(6): 1725-1726, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-36809405
5.
Increasing Annual Cancer Incidence in Patients Age 20-49 Years: A Real-Data Study.
JCO Glob Oncol
; 10: e2300363, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38513186
6.
HMGB1 Expression Levels Correlate with Response to Immunotherapy in Non-Small Cell Lung Cancer.
Lung Cancer (Auckl)
; 15: 55-67, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38741920
7.
First-line avelumab plus chemotherapy in patients with advanced solid tumors: results from the phase 1b/2 JAVELIN Chemotherapy Medley study.
Cancer Res Commun
; 2024 Apr 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-38669053
8.
Praluzatamab Ravtansine, a CD166-Targeting Antibody-Drug Conjugate, in Patients with Advanced Solid Tumors: An Open-Label Phase I/II Trial.
Clin Cancer Res
; 28(10): 2020-2029, 2022 05 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-35165101
9.
Phase I, First-in-Human Study of the Probody Therapeutic CX-2029 in Adults with Advanced Solid Tumor Malignancies.
Clin Cancer Res
; 27(16): 4521-4530, 2021 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34083236
10.
CX-072 (pacmilimab), a Probody PD-L1 inhibitor, in combination with ipilimumab in patients with advanced solid tumors (PROCLAIM-CX-072): a first-in-human, dose-finding study.
J Immunother Cancer
; 9(7)2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34301808
11.
Case Report: A Case Study Documenting the Activity of Atezolizumab in a PD-L1-Negative Triple-Negative Breast Cancer.
Front Oncol
; 11: 710596, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34616675
12.
CX-072 (pacmilimab), a Probody ® PD-L1 inhibitor, in advanced or recurrent solid tumors (PROCLAIM-CX-072): an open-label dose-finding and first-in-human study.
J Immunother Cancer
; 9(7)2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34301809
13.
Assessment of the Feasibility and Safety of Durvalumab for Treatment of Solid Tumors in Patients With HIV-1 Infection: The Phase 2 DURVAST Study.
JAMA Oncol
; 6(7): 1063-1067, 2020 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32271353
14.
POSEIDON Trial Phase 1b Results: Safety, Efficacy and Circulating Tumor DNA Response of the Beta Isoform-Sparing PI3K Inhibitor Taselisib (GDC-0032) Combined with Tamoxifen in Hormone Receptor Positive Metastatic Breast Cancer Patients.
Clin Cancer Res
; 25(22): 6598-6605, 2019 11 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31439579
15.
Unexpected Durable Complete Response With Anti-PD-L1 Blockade in Metastatic Undifferentiated Pleomorphic Sarcoma: A Case Report With Host and Tumor Biomarker Analysis.
JCO Precis Oncol
; 7: e2300051, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37856765
16.
Enhanced detection of circulating tumor DNA by fragment size analysis.
Sci Transl Med
; 10(466)2018 11 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30404863
17.
Liquid biopsies come of age: towards implementation of circulating tumour DNA.
Nat Rev Cancer
; 17(4): 223-238, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28233803
18.
A phase I pharmacokinetic and safety study of cabazitaxel in adult cancer patients with normal and impaired renal function.
Cancer Chemother Pharmacol
; 78(6): 1185-1197, 2016 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-27796539
Resultados
1 -
18
de 18
1
Próxima >
>>